IBMJuly 30, 2026 at 10:00 AM UTCSoftware & Services

IBM Quantum Advance Validates Long-Term Tech Mojo; Near-Term Stock Still Tied to Q3 Execution

Read source article

What happened

IBM and the University of Chicago demonstrated quantum advantage using 70 logical qubits and a new error correction method, solving a classically intractable problem in about 15 minutes. The breakthrough strengthens IBM's position in the emerging quantum computing race, but commercial revenue from quantum systems remains years away. The latest DeepValue master report rates IBM a POTENTIAL BUY, focusing on near-term software reacceleration and consulting conversion in Q3 rather than multi-year science projects. The market continues to price IBM as an AI spending loser, and quantum announcements have historically done little to change that near-term narrative. Consequently, while the news is a feather in IBM's innovation cap, it won't shift the needle on the Q3 software and consulting checkpoints that drive the investment thesis.

Implication

The quantum demonstration is a meaningful scientific achievement that underscores IBM's R&D capabilities and long-term optionality in a potentially transformative technology. However, investors should view it as a science milestone rather than a near-term business catalyst, as quantum computing likely won't contribute material revenue for several years. The Master Report's thesis rests on concrete Q3 metrics: software growth above 5%, consulting revenue turning positive, and backlog conversion in infrastructure. Until IBM reports those numbers, the stock will remain hostage to fears about enterprise budget rotation toward AI infrastructure. The quantum news could marginally bolster sentiment among tech-focused investors, but it does not de-risk the near-term uncertainty that has driven the stock to $205.

Thesis delta

The quantum milestone adds a positive technology narrative but does not change the near-term investment thesis, which still depends on Q3 software growth and consulting conversion. It reinforces IBM's long-term optionality in quantum computing, but the market's immediate focus remains on enterprise budget reallocation toward AI servers and storage. The thesis that IBM is undervalued if it can prove software and consulting resilience is unaffected by this development.

Confidence

Moderate - the quantum advance is promising but unlikely to affect near-term stock performance, keeping the focus on Q3 earnings.